APA

Pepin X. J. H., Flanagan T. R., Holt D. J., Eidelman A., Treacy D. & Rowlings C. E. (20171024). Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets. : Molecular pharmaceutics.

Chicago

Pepin Xavier J H, Flanagan Talia R, Holt David J, Eidelman Anna, Treacy Don and Rowlings Colin E. 20171024. Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets. : Molecular pharmaceutics.

Harvard

Pepin X. J. H., Flanagan T. R., Holt D. J., Eidelman A., Treacy D. and Rowlings C. E. (20171024). Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets. : Molecular pharmaceutics.

MLA

Pepin Xavier J H, Flanagan Talia R, Holt David J, Eidelman Anna, Treacy Don and Rowlings Colin E. Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets. : Molecular pharmaceutics. 20171024.